Taiwan promotes smart medical device innovation and market growth

On April 28, 2025, the Taiwan Food and Drug Administration (TFDA) organized an important industrial exchange event in Taipei City, focusing on the market expansion of smart medical equipment. This initiative reflects the government's determination to enhance the nation's global competitiveness through cross-sector integration. The event was facilitated by the Research Center for Biotechnology and Medicine Policy based in Taipei, and it brought together a diverse audience, including academics, officials, business representatives, and medical staff from across the country to exchange valuable knowledge and experiences. One of the notable aspects of the event was the technology demonstration and business matching services, which provided opportunities for networking and collaboration among participants. Additionally, consultations regarding relevant laws and regulations pertaining to smart medical devices were offered. The TFDA emphasized the significance of keynote speeches that addressed the latest global developments in the field of smart medical devices, underscoring the potential for innovation and advancement in healthcare technologies. A total of nine teams showcased their innovative technologies during the meeting, with projects ranging from brain wave monitoring equipment to a liver cancer recurrence prediction platform, and even a 5G multi-parameter physiological monitoring system. These demonstrations not only highlight the creativity and capabilities within Taiwan's medical technology sector but also reflect the government's commitment to implementing various projects aimed at improving health outcomes in the country. The TFDA is dedicated to achieving a healthier Taiwan through initiatives that support enterprises in applying smart medical technology for health promotion and chronic disease prevention. Furthermore, the administration aims to strengthen the national cancer prevention and control plan, while working in conjunction with the private sector to boost industrial development. To date, the TFDA has successfully approved 180 licenses for medical devices that incorporate artificial intelligence from 2020 to March 2025. This progress is a testament to the TFDA's effectiveness and its call for Taiwan to accelerate innovation and resource integration as it navigates the rapidly growing global smart medical market.